SEC Form 4 · accession 0001615774-17-004477
Inspyr Therapeutics, Inc. · NSPX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Bo Jesper Hansen
Director
Period of report
Aug 14, 2017
Accepted (ET)
Aug 15, 2017 · 5:25 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001421204
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock Purchase OptionF1 | $0.35 | Aug 14, 2017 | A | 1,667 | A | Aug 14, 2017 | Aug 14, 2022 | Common Stock | 1,667 | 1,667 | D |
Explanation of responses
- F1Represents compensatory Annual Grant for director services. The options vest quarterly on 11/14/17, 2/14/18, 5/14/18, and 8/14/18.